Stay updated on Atezo & Tiragolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.

Latest updates to the Atezo & Tiragolumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the recorded trial information.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0 from the history log.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision v3.5.0 was added to the Record History. Revision v3.4.3 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry (v3.4.3) was added to the history, and the previous revision entry (v3.4.2) was removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.2 was added to the history. Notices about government funding lapse and Revision: v3.4.1 were removed from the page.SummaryDifference0.7%

- Check92 days agoChange DetectedAdded a banner about a lapse in government funding and operating status; updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.7%

Stay in the know with updates to Atezo & Tiragolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.